Navigation Links
Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor
Date:2/12/2008

YUCAIPA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Ingen Technologies, Inc. (OTC Bulletin Board: IGTG), a medical device manufacturer, announced today the signed distribution agreement with Progressive International Holding Co. LTD in Hong Kong to distribute Oxyview(R) in Taiwan, People's Republic of China, Japan and Korea. Please refer to the 8-K filing of this event.

Progressive International Holding Company (PIHK) (http://www.pgiholding.com) and its associate company, Progressive Group Inc (PGI), was founded in 1983 and is one of the major distributors of clinical diagnostic systems, medical devices and point of care products in Taiwan. To pursue the potential business opportunity in China and fully capitalize PGI's sales & marketing experience of more than twenty years, PGI established Progressive International Holding Company (PIHK) in Hong Kong in 2005. PIHK has tremendous synergy by utilizing the experience, expertise and connections of PGI in China and Taiwan to expand its product portfolio in patient oxygen gas flow monitoring devices in the China, Japan and Korea markets.

The distribution agreement calls for a monthly minimum of 10,000 Oxyview(R) units to be purchased by PIHK during a five year period. PIHK has submitted the application to the Chinese government agency known as SFDA for registration of the free sales certificate.

"Ingen looks forward to working closely with Progressive. Julian Yuan, CEO of Progressive, visited our manufacturing facilities last year. Mr. Yuan is CEO of Aviva Biosciences in San Diego, California (http://www.avivabio.com), and has the resources to deliver Oxyview(R) to the Asian markets. Our company is pleased to have the privilege of working with Progressive International Holding Company," stated Scott Sand, Chairman and CEO of Ingen Technologies.

For more information please vis
'/>"/>

SOURCE Ingen Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
2. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
3. Ingen Technologies, Inc. Press Release Retraction
4. Ingenious Med Reports Record Sales and Client Expansions in 2007
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
9. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
10. Advanced technologies aim to transform the coaching of top athletes
11. Global Med Technologies(R) Extends Its Worldwide Outreach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...Susan Butcher the famous iditarod champion was det...rticipate in the 300-mile sled dog race conducted ...of the 1100-mile Iditarod Trail Sled Dog Race. She...ce of survival with the same grit and confidence. ...
...There appears to be a remarkable laxity among the ...ng skin cancer. Felipe Beltran, the spokesman for ... has admitted that the organization’s drive agains...ed impact. The online study of the QIMR did not e...
...Researchers from Germany have discovered a novel, ...of coronary veins. This technique, called ECG-gate...DCT, is associated with very few complications // ... improved diagnostic quality and treatment. A com...
...A research was conducted by Selda Samakoglu and co...nter. This research opened new doors in the treatm.... The treatment combines both gene therapy and RNA...eatment has worked well in the laboratory stage an...
Other Medicine News:Health News:Treatment of Sickle Cell Anemia Using Gene Therapy. 2
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific...stCall/ -- Ironwood,Pharmaceuticals, Inc. (formerl...YSE: FRX ) today announced the presentation of re...s safety and efficacy in 420 patients with,irritab...sis of the data,indicates that once- daily oral do...
(Date:10/7/2008)...RKELEY, Calif., Oct. 7 /- Aerovance I... data from a Phase I trial of its Aerovant,inhalat... no evidence of,local irritancy following asthma p... 10 mg dose will be the highest of three doses inv...udy, which is scheduled to begin early,next year. ...
(Date:10/7/2008)...tient, Prospective Randomized Placebo-Controlled P...cant Improved Overall Survival., MOUNTAIN VIEW, C...apeutics has now evaluated the mature Phase II dat...didate PROSTVAC(TM) that had been,obtained as part...onal,Cancer Institute (NCI) in the US., The resul...
(Date:10/7/2008)...nned 15 Patient Cohort Enrolled in Stage A of Tria...on With Carboplatin and Paclitaxel -, TUSTIN, Cal...armaceuticals, Inc. (Nasdaq: PPHM ), a clinical s...al antibodies for the treatment of cancer and,hepa...t it has completed,enrollment in the first stage o...
Breaking Medicine Technology:Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4CorVel Announces Appearance at Bank of America Health Care Conference 18732 1CorVel Announces Appearance at Bank of America Health Care Conference 18732 2San Diego State University Controlled Substance Investigation 18730 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 2Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 1Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 2
... Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Gloucester...rmaceutical,company, announced today that encourag...mbination of romidepsin and erlotinib in,non-small...human,cancer patients were presented at the Americ...eeting taking place in Los Angles,CA. The study w...
...ies Confirm That Fusion Proteins Made by Combining...onstrate Increased,Anti-Tumor Activity With No Obs..., April 18, 2007,/PRNewswire-FirstCall/ -- Peregri...rmaceutical company developing targeted,monoclonal...tis C,virus infection, today reported that data pr...
Other Medicine Technology:Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 2Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 2Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 4
...ing: The Procleix System has added a significant ... utilizes innovative technologies developed by Gen...eic acid amplification technique called Transcript...V-1/HCV Assay can simultaneously detect the presen...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...assay: Uni-Gold Recombigen HIV is a single use rap...in plasma, serum and whole blood (venipuncture). U...t of care settings as an aid in diagnosis of infec...appropriate multi-test algorithms designed for the...
The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide
Medicine Products: